

ä»é±æ°ã«ãªã£ãæµ·å€ã®ãã¥ãŒã¹ã
çœå®³æã«æå¹æŽ»çšã§ããããšãããããã©ã
æšå¹Žã¢ã¡ãªã«ã襲ã£ã倧坿³¢ã§åã³é¡ãã«ãªã£ããå¯ãã«å¯ŸããEVè»ã®åŒ±ç¹ã
ããã§ããæ¬§å·ã«ãããŠåæ§ã«é²ãããããã¬ãœãªã³è»å»æ¢ãè£å©éå¶åºŠã«ããEVè»æ¡å€§ãšå¯ãã«åŒ·ãEVè»ã®éçºã
SDGïœãäž»å°ããŠããæ¬§å·ã
ãããããæ¬§å·ãå®ããåºæºããã¯ãªãŒã³ãšãã«ã®ãŒã®åºæºãšãªãããšã
ïŒïŒïŒïŒå¹ŽïŒïŒæã®èšäºã ããã©ãå°è±¡ã«æ®ã£ãŠããèŠç¹ã
ãã®ããã«æ¬§å·ã¡ãŒã«ãŒïŒããã³ç±³åœã¡ãŒã«ãŒããããŠäžåœã¡ãŒã«ãŒãïŒã¯åªãããã€ããªããè»ãéçºã§ããªãã£ãããããããªãããåçŽãªæè¡ã§äœããEVããã³ãŸãããåºæºã®PHEVã«ç¹åããŠããã®ã§ããã
ãã€ããªããã¯ã¬ãœãªã³è»ãšEVã®äžéã«ãããã¯ãæä»£é
ãã®æè¡ããšããèŠæ¹ãæ ¹æ¬çã«ééã£ãŠããããšããçè§£ããã ããã§ããããã
ãã€ããªããæè¡ãšã¯ãæ¥æ¬ã ãããã®ã«ã§ãããäžçã«èªãå 端æè¡ãªã®ã§ããã
ãã€ããªããæè¡ãšã¯ãæ¥æ¬ã ãããã®ã«ã§ãããäžçã«èªãå 端æè¡ãªã®ã§ããã
å€ãã®äºãå€ãã£ãŠããã ãããšæããããããããã®ïŒïŒå¹Žã
絊油æãã¬ã¹ã³ã³ããã¬ã¹çµŠæ¹¯åšãæ¥åžžé¢šæ¯ããæ¶ããæ¥ãã
ããé ããªãã®ãããããªãã
ã»çŠæ¢ããããšããŠãã察象ã«ãªãã®ã¯ãæ°ãã補åã®ã¿ã§ãããæ¢åã®è£œåã«é©çšãããããšã¯ãªããã
ã»ãã¥ãŒãšãŒã¯ãªã©ç±³åœã®äžéšã®éœåžã§ã¯ãæ°ãã«å»ºç©ã建èšããéãæž©å®€å¹æã¬ã¹æåºåæžã®èгç¹ããã倩ç¶ã¬ã¹ã®é 管èšçœ®ããã§ã«çŠæ¢ããŠãããæšå¹ŽïŒæã®æç¹ã§ãå ±åå ãäž»å°æš©ã®æ¡ãïŒïŒã®å·ã§ã¯ãåéœåžã«å€©ç¶ã¬ã¹çŠæ¢ã®æ³åŸãæç«ããã
ã»ãã¥ãŒãšãŒã¯ãªã©ç±³åœã®äžéšã®éœåžã§ã¯ãæ°ãã«å»ºç©ã建èšããéãæž©å®€å¹æã¬ã¹æåºåæžã®èгç¹ããã倩ç¶ã¬ã¹ã®é 管èšçœ®ããã§ã«çŠæ¢ããŠãããæšå¹ŽïŒæã®æç¹ã§ãå ±åå ãäž»å°æš©ã®æ¡ãïŒïŒã®å·ã§ã¯ãåéœåžã«å€©ç¶ã¬ã¹çŠæ¢ã®æ³åŸãæç«ããã
ããäžã€ãæ°ã«ãªã£ããã¥ãŒã¹ã
FDAãä»åŸå
šãŠã®å»è¬åã«ã€ããŠããã詊éšåã®åç©å®éšã矩åã¥ãã
æ°ããæ³åŸã«ãããæ°åå¹Žã«æž¡ããå»è¬å詊éšã®èŠä»¶ã倧ãã調æŽãž
éšåçã«æç²ããŠåèš³
ç±³åœé£åå»è¬åå±ïŒFDAïŒã«ãããã¹ãŠã®æ°è¬æ¿èªããã»ã¹ã«ãããŠãåç©å®éšã矩åã¥ããããªããªãã1938幎以æ¥ãFDAã®æ¿èªãåŸãããã補è¬äŒç€Ÿã¯äººäœå®éšã«é²ãåã«ãç¹°ãè¿ãåç©å®éšãè¡ããè¬ã宿ãããªããã°ãªããªãã£ãã
ããã¯ãåç©æè·å£äœãäžéšã®è£œè¬äŒç€Ÿãé·ãé䞻匵ããŠããããšã§ãããäžæ¹ãç ç©¶è ã®åå¿ã¯æ§ã ã§ããã®åããããã«å€åããããããšã¯æããªããšãã人ãããã°ããã®å¯èœæ§ã«æåŸ ããŠãã人ãããããå®å šæ§ã«æžå¿µãæ±ããŠãã人ãããã
åç©å®éšã®ä»£ããã«ãã³ã³ãã¥ãŒã¿ã»ã·ãã¥ã¬ãŒã·ã§ã³ãèåšãããã3Dããªã³ã¿ãŒã§äœãããäœã®äžéšãªã©ãæè¡ã®é²æ©ã«å¯Ÿå¿ããåç©å®éšãå«ããéèšåºè©ŠéšããçµãŠãæ°è¬ã¯ããã§ã®èšåºè©Šéšã«ç§»è¡ããããšãã§ããããã«ãªãã
é£éŠäºç®æ¡ã«ã¯ãåç©å®éšãæžãããæ°ããæ¹è¯ãããå®é𿹿³ãéçºããããšãç®çãšããFDAã®ç ç©¶è²»ãšããŠ500äžãã«ãå«ãŸããŠããã
ãããŸã§FDAã¯ãææ¡ãããå»è¬åã«ã€ããŠãããºãïŒå®éšçšã©ãããããŠã¹ïŒãšãµã«ãã€ãã®ãããªéããºãç§åç©1å¹ã®æ¯æ§è©Šéšã®å®æœãèŠæ±ããŠããããããããããã®è©ŠéšãçµãŠããã®èšåºè©Šéšã«ç§»è¡ããå»è¬åã®å§åç倿°ã¯ãäŸç¶ãšããŠå®å šã§ãªãããããã¯å¹æããªããšå€æãããŠããã2019幎ã®ãã調æ»ã«ãããšããã詊éšã«å ¥ã£ãè¬ã®95ïŒ è¿ããFDAã®æ¿èªãåŸããããåç©å®éšã¯ããŸãæå¹ãªãã£ã«ã¿ãŒã«ãªããªãããã ãã©ããã®äœå çç©åŠã¯ç¬ã®ãããšã¯ç°ãªããããã¯ããªãã¡äººéã®ãããšã¯ç°ãªãã
ããŒããŒã倧åŠã®çç©å·¥åŠè ã§ãããã³ã»ã€ã³ã°ããŒã¯Scienceèªã«ãåç©ã¢ãã«ã¯æ£ãããããééã£ãŠããããšã®æ¹ãå€ãããšè¿°ã¹ãŠããã
åç©å®éšã«äŒŽãå€é¡ã®è²»çšãæœåšçãªæ®é ·ãã確å®ãªæ»ã¯èšããŸã§ããªããç±³åœã§ã¯æ¯å¹Žãäœåäžå¹ãã®åç©ïŒäž»ã«ãã£æ¯é¡ïŒãå®éšå®€ã§ã®ç ç©¶ãè¬ç©è©Šéšã«äœ¿ãããŠããããããŠããã®ã»ãšãã©ãå®éšçµäºåŸã«æ®ºãããŠããã
次ã«äœãèµ·ãããïŒ
ããããªãããåç©å®éšã«ä»£ãããã€ãã¯æè¡ã®ã»ãšãã©ã¯ããŸã 補è¬äŒç€Ÿã®èšåºè©ŠéšãåŒãç¶ãæºåãã§ããŠããªããšãåç©å®éšãæè·ããå£äœAmerican for Medical Progressã®ã³ãã¥ãã±ãŒã·ã§ã³ãã£ã¬ã¯ã¿ãŒã§ãããžã ã»ãã¥ãŒãã³æ°ã¯Scienceèªã«èªã£ãã
ãããã®ä»£æ¿æ³ã¯ãåææ®µéãã§ããããäœå¹Žãäœå¹Žããåç©ã¢ãã«ã«åã£ãŠä»£ããããšã¯ã§ããªãã ããããšåœŒã¯èšãããã®çµæãFDAããã®èŠä»¶ããããã³ã«ãããã«å€§ããå€ããããšã¯ãªãã ããããšåœŒã¯èããŠããã
ã¢ã€ãªã¯å€§åŠã®è¬çåŠç ç©¶è ã§ããAliasger Salemæ°ã¯ãNPRã®å ±éã§ãæ°ããä»£æ¿æè¡ã«å¯Ÿãããã¥ãŒãã³ã®æççãªèŠæ¹ãç¹°ãè¿ããããäŒæ¥ã¯ããããã®æè¡ã®éçãšãæœåšçãªæ¯æ§ãç¹å®ããèœåããããã¯ç¹å®ããªãèœåãèªèããå¿ èŠããããŸããããšSalemæ°ã¯è¿°ã¹ãã
ãéå»ã«ç¢ºèªã§ããæ¯æ§ããå šãŠææ¡ã§ããªãå¯èœæ§ãããã·ã¹ãã ã«ã¯ç§»è¡ããããªãã¯ãã§ãã åç©å®éšããä»£æ¿æ³ãžã®ç§»è¡ã¯ãã£ããè¡ãããã§ãããããå€ãã®å»è¬å詊éšã§åç©å®éšãè¡ãããããšã«å€ããã¯ãªãã§ããããã
ããã¯ãåç©æè·å£äœãäžéšã®è£œè¬äŒç€Ÿãé·ãé䞻匵ããŠããããšã§ãããäžæ¹ãç ç©¶è ã®åå¿ã¯æ§ã ã§ããã®åããããã«å€åããããããšã¯æããªããšãã人ãããã°ããã®å¯èœæ§ã«æåŸ ããŠãã人ãããããå®å šæ§ã«æžå¿µãæ±ããŠãã人ãããã
åç©å®éšã®ä»£ããã«ãã³ã³ãã¥ãŒã¿ã»ã·ãã¥ã¬ãŒã·ã§ã³ãèåšãããã3Dããªã³ã¿ãŒã§äœãããäœã®äžéšãªã©ãæè¡ã®é²æ©ã«å¯Ÿå¿ããåç©å®éšãå«ããéèšåºè©ŠéšããçµãŠãæ°è¬ã¯ããã§ã®èšåºè©Šéšã«ç§»è¡ããããšãã§ããããã«ãªãã
é£éŠäºç®æ¡ã«ã¯ãåç©å®éšãæžãããæ°ããæ¹è¯ãããå®é𿹿³ãéçºããããšãç®çãšããFDAã®ç ç©¶è²»ãšããŠ500äžãã«ãå«ãŸããŠããã
ãããŸã§FDAã¯ãææ¡ãããå»è¬åã«ã€ããŠãããºãïŒå®éšçšã©ãããããŠã¹ïŒãšãµã«ãã€ãã®ãããªéããºãç§åç©1å¹ã®æ¯æ§è©Šéšã®å®æœãèŠæ±ããŠããããããããããã®è©ŠéšãçµãŠããã®èšåºè©Šéšã«ç§»è¡ããå»è¬åã®å§åç倿°ã¯ãäŸç¶ãšããŠå®å šã§ãªãããããã¯å¹æããªããšå€æãããŠããã2019幎ã®ãã調æ»ã«ãããšããã詊éšã«å ¥ã£ãè¬ã®95ïŒ è¿ããFDAã®æ¿èªãåŸããããåç©å®éšã¯ããŸãæå¹ãªãã£ã«ã¿ãŒã«ãªããªãããã ãã©ããã®äœå çç©åŠã¯ç¬ã®ãããšã¯ç°ãªããããã¯ããªãã¡äººéã®ãããšã¯ç°ãªãã
ããŒããŒã倧åŠã®çç©å·¥åŠè ã§ãããã³ã»ã€ã³ã°ããŒã¯Scienceèªã«ãåç©ã¢ãã«ã¯æ£ãããããééã£ãŠããããšã®æ¹ãå€ãããšè¿°ã¹ãŠããã
åç©å®éšã«äŒŽãå€é¡ã®è²»çšãæœåšçãªæ®é ·ãã確å®ãªæ»ã¯èšããŸã§ããªããç±³åœã§ã¯æ¯å¹Žãäœåäžå¹ãã®åç©ïŒäž»ã«ãã£æ¯é¡ïŒãå®éšå®€ã§ã®ç ç©¶ãè¬ç©è©Šéšã«äœ¿ãããŠããããããŠããã®ã»ãšãã©ãå®éšçµäºåŸã«æ®ºãããŠããã
次ã«äœãèµ·ãããïŒ
ããããªãããåç©å®éšã«ä»£ãããã€ãã¯æè¡ã®ã»ãšãã©ã¯ããŸã 補è¬äŒç€Ÿã®èšåºè©ŠéšãåŒãç¶ãæºåãã§ããŠããªããšãåç©å®éšãæè·ããå£äœAmerican for Medical Progressã®ã³ãã¥ãã±ãŒã·ã§ã³ãã£ã¬ã¯ã¿ãŒã§ãããžã ã»ãã¥ãŒãã³æ°ã¯Scienceèªã«èªã£ãã
ãããã®ä»£æ¿æ³ã¯ãåææ®µéãã§ããããäœå¹Žãäœå¹Žããåç©ã¢ãã«ã«åã£ãŠä»£ããããšã¯ã§ããªãã ããããšåœŒã¯èšãããã®çµæãFDAããã®èŠä»¶ããããã³ã«ãããã«å€§ããå€ããããšã¯ãªãã ããããšåœŒã¯èããŠããã
ã¢ã€ãªã¯å€§åŠã®è¬çåŠç ç©¶è ã§ããAliasger Salemæ°ã¯ãNPRã®å ±éã§ãæ°ããä»£æ¿æè¡ã«å¯Ÿãããã¥ãŒãã³ã®æççãªèŠæ¹ãç¹°ãè¿ããããäŒæ¥ã¯ããããã®æè¡ã®éçãšãæœåšçãªæ¯æ§ãç¹å®ããèœåããããã¯ç¹å®ããªãèœåãèªèããå¿ èŠããããŸããããšSalemæ°ã¯è¿°ã¹ãã
ãéå»ã«ç¢ºèªã§ããæ¯æ§ããå šãŠææ¡ã§ããªãå¯èœæ§ãããã·ã¹ãã ã«ã¯ç§»è¡ããããªãã¯ãã§ãã åç©å®éšããä»£æ¿æ³ãžã®ç§»è¡ã¯ãã£ããè¡ãããã§ãããããå€ãã®å»è¬å詊éšã§åç©å®éšãè¡ãããããšã«å€ããã¯ãªãã§ããããã
- é¢é£èšäº
-
-
EUãæ¿èªãé£åã«äžãæè«ã»ã³ãªãã®é£ 2023/01/27
-
ã¬ã¹ã³ã³ã ãš åã©ãã®ADHDã®é¢é£æ§ãè¿°ã¹ã 欧å·ã®å ±åæž 2023/01/15
-
ç±³åœãã¬ã¹ã³ã³ãçŠæ¢æªçœ®ãåç©å®éšçŸ©åæ€å» 2023/01/14
-
é£ã¶ã¯ã¯ãã³ 2023/01/09
-
EUã倩ç¶ã¬ã¹ã»åååãæç¶å¯èœãªçµæžæŽ»åãšå¶å® 2022/07/18
-
ã¹ãã³ãµãŒãµã€ã
ã³ã¡ã³ã